Spatial transcriptomics analysis to predict response to immune checkpoint blockade (ICB) in recurrent or metastatic head and neck squamous cell cancer (RM-HNSCC).
Abstract
6045 Background: Spatial transcriptomics (ST) revealed conserved malignant leading edge (LE) and tumor core (TC) architectures in primary oral squamous cell carcinoma (OSCC) with potential for biomarker discovery. Spatial organization of tumor cells, as well as composition and prognostic significance of neighboring stromal cells in RM-HNSCC remain unknown. Methods: 21 tumor biopsy samples (14 baseline, 7 paired on-treatment) from 14 ICB-naive RM-HNSCC patients (pts) treated with pembrolizumab in INSPIRE (NCT02644369) were profiled using 10x Visium. Spatial organization was refined by scoring LE and TC gene sets identified in OSCC (Arora and Bose et al. Nat Comm 2023). Malignant (2,671 spots) and nonmalignant (8,177 spots) subclusters were annotated, with the latter classified into five cell subtypes using canonical markers: tumor-associated macrophages (TAMs) ( CD68 , CD14 , SCF1R ), regulatory stromal cells (reg) ( KRT17 , COL10A1 , SRBP1 ), plasma cells ( CD38 , IRF4 , PRDM1 ), T cells ( CD3D , CD3E , PTPRC ), and cancer-associated fibroblasts (CAFs) ( FAP , COL1A1 , PDGFRB ). Neighborhood analyses compared normalized counts of stromal cells adjacent to LE and TC, accounting for variations in cell density and sampling differences. A signature was built through k -means clustering of the five cell subtypes. Pts were stratified into high/low signature-score groups using the median cutoff and tested for association with progression-free survival (PFS). Results: Spatial organization revealed conserved malignant subclusters (C0 and C1) in 19/21 samples from 13 pts (11 non-responders). Top C0 genes were COL21A1 , S1PR3 , LIFR , and ZEB1 . Top C1 genes were KRT6B , KRT6C , KRTDAP , and LCN2 . Pathway analysis predicted activation of cell cycle and glycoprotein 6 in C0, and keratinization and neutrophil degranulation in C1. Comparative expression of OSCC-related gene sets revealed LE correlation with C0, and TC correlation with C1 (both p < 0.0001); stronger overlap was seen with the latter highlighting TC as a more conserved feature in HNSCC. Among non-responders, dominant communication patterns in LE and TC included claudins, cadherins, WNT, and IL-6, linked to cell adhesion, migration/invasion, and immune evasion. Signature generated by neighborhood analysis was enriched in TAMs and T cells, depleted in CAFs and reg near LE and TC, while plasma cells were depleted near LE but enriched near TC. Pts with high signature scores (6/13) exhibited improved PFS compared to low scores (7/13), median PFS 6.0 months [95% CI, 2.3-NA] versus 1.9 months [95% CI, 1.8-NA] (p = 0.059). Conclusions: To our knowledge, this is the first report using ST analysis to characterize LE and TC architectures in RM-HNSCC, along with heterogeneous neighboring stromal cells with prognostic potential for ICB. Ongoing cohort expansion will elucidate the clinical significance of these findings.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (12)
Grégoire Marret
Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada
Jinsu An
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
Lucas Penny
Department of Medical Biophysics, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada
Ben Wang
State Key Laboratory of Flexible Electronics (LoFE) & Institute of Advanced Materials (IAM), Nanjing University of Posts & Telecommunications, 9 Wenyuan Road, Nanjing 210023, China
Azin Sayad
Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
Anna Spreafico
Enrique Sanz Garcia
Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
Aaron Richard Hansen
Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
Helen Chow
Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
Scott Bratman
1Princess Margaret Cancer Centre - University Health Network, Toronto, Canada
Pinaki Bose
Lillian L. Siu
Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto